Causes and consequences of increased glucose metabolism of cancers

被引:480
作者
Gillies, Robert J. [1 ]
Robey, Ian [1 ]
Gatenby, Robert A. [1 ]
机构
[1] Univ Arizona, Tucson, AZ USA
关键词
cancer; glucose; metabolism; carcinogenesis; acid-base; somatic evolution;
D O I
10.2967/jnumed.107.047258
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In this review we examine the mechanisms (causes) underlying the increased glucose consumption observed in tumors within a teleological context (consequences). In other words, we will ask not only "How do cancers have high glycolysis?" but also, "Why?" We believe that the insights gained from answering the latter question support the conclusion that elevated glucose consumption is a necessary component of carcinogenesis. Specifically we propose that glycolysis is elevated because it produces acid, which provides an evolutionary advantage to cancer cells vis-a-vis normal parenchyma into which they invade.
引用
收藏
页码:24S / 42S
页数:19
相关论文
共 257 条
  • [1] Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography
    Abbey, Craig K.
    Borowsky, Alexander D.
    Gregg, Jeffery P.
    Cardiff, Robert D.
    Cherry, Simon R.
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2006, 11 (02) : 137 - 149
  • [2] Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings
    Abdel-Nabi, H
    Doerr, RJ
    Lamonica, DM
    Cronin, VR
    Galantowicz, P
    Carbone, GM
    Spaulding, MB
    [J]. RADIOLOGY, 1998, 206 (03) : 755 - 760
  • [3] Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer
    Abe, K
    Sasaki, M
    Kuwabara, Y
    Koga, H
    Baba, S
    Hayashi, K
    Takahashi, N
    Honda, H
    [J]. ANNALS OF NUCLEAR MEDICINE, 2005, 19 (07) : 573 - 579
  • [4] Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer
    Adams, S
    Baum, RP
    Stuckensen, T
    Bitter, K
    Hör, G
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) : 1255 - 1260
  • [5] Axillary lymph node metastases: Screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET
    Adler, LP
    Faulhaber, PF
    Schnur, KC
    AlKasi, NL
    Shenk, RR
    [J]. RADIOLOGY, 1997, 203 (02) : 323 - 327
  • [6] Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases:: a comparison with CT
    Aide, N
    Cappele, O
    Bottet, P
    Bensadoun, H
    Regeasse, A
    Comoz, F
    Sobrio, F
    Bouvard, G
    Agostini, D
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (09) : 1236 - 1245
  • [7] Aime S, 2002, ANGEW CHEM INT EDIT, V41, P4334, DOI 10.1002/1521-3773(20021115)41:22<4334::AID-ANIE4334>3.0.CO
  • [8] 2-1
  • [9] Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications
    Aime, S
    Barge, A
    Delli Castelli, D
    Fedeli, F
    Mortillaro, A
    Nielsen, FU
    Terreno, E
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2002, 47 (04) : 639 - 648
  • [10] A R2/R1 ratiometric procedure for a concentration-independent, pH-responsive, Gd(III)-based MRI agent
    Aime, Silvio
    Fedeli, Franco
    Sanino, Alberto
    Terreno, Enzo
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (35) : 11326 - 11327